Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil

Infection, Genetics and Evolution

Volumn 12, Issue 5, 2012, Pages 1102-1110

  Castellucci, Léa ^a   Jamieson, Sarra E ^b   Almeida, Lucas ^a   Oliveira, Joyce ^a   Guimarães, Luiz Henrique ^a   Lessa, Marcus ^a   Fakiola, Michaela ^b,c   Jesus, Amélia Ribeiro de ^a,d,e   Nancy Miller, E ^c   Carvalho, Edgar M ^a   Blackwell, Jenefer M ^b,c  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d Instituto de Investigacao em Imunologia   (Brazil)

^e FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

CTGF; FLII; Leishmaniasis; SMADs; TGFB pathway; Wound healing

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; BRAZIL; COHORT ANALYSIS; CONTROLLED STUDY; CTGF GENE; DISEASE PREDISPOSITION; FEMALE; FLI1 GENE; GENE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR FAMILY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN LEISHMANIASIS; SMADS2 GENE; SMADS3 GENE; SMADS4 GENE; SMADS7 GENE; TGFB1 GENE; TGFBR1 GENE; TGFBR2 GENE; WOUND HEALING; WOUND HEALING GENE;

ADULT; BRAZIL; COHORT STUDIES; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LEISHMANIASIS, CUTANEOUS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MICROFILAMENT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

LEISHMANIA BRAZILIENSIS; LEISHMANIA MAJOR;

EID: 84860356660     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.03.017     Document Type: Article

References (41)

1. Asano Y. Future treatments in systemic sclerosis. J. Dermatol. 2010, 37:54-70.
2. Bacellar O., Lessa H., Schriefer A., Machado P., Ribeiro de Jesus A., Dutra W.O., Gollob K.J., Carvalho E.M. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect. Immun. 2002, 70:6734-6740.
3. Barrientos S., Stojadinovic O., Golinko M.S., Brem H., Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008, 16:585-601.
4. Blackwell J.M., Fakiola M., Ibrahim M.E., Jamieson S.E., Jeronimo S.B., Miller E.N., Mishra A., Mohamed H.S., Peacock C.S., Raju M., Sundar S., Wilson M.E. Genetics and visceral leishmaniasis: of mice and man. Parasite Immunol. 2009, 31:254-266.
5. Cabrera M., Shaw M.-A., Sharples C., Williams H., Castes M., Convit J., Blackwell J.M. Polymorphism in TNF genes associated with mucocutaneous leishmaniasis. J. Exp. Med. 1995, 182:1259-1264.
6. Castellucci L., Menezes E., Oliveira J., Magalhaes A., Guimaraes L.H., Lessa M., Ribeiro S., Reale J., Noronha E.F., Wilson M.E., Duggal P., Beaty T.H., Jeronimo S., Jamieson S.E., Bales A., Blackwell J.M., de Jesus A.R., Carvalho E.M. IL6-174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J. Infect. Dis. 2006, 194:519-527.
7. Castellucci L., Jamieson S.E., Miller E.N., Menezes E., Oliveira J., Magalhaes A., Guimaraes L.H., Lessa M., de Jesus A.R., Carvalho E.M., Blackwell J.M. CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study. BMC Med. Genet. 2010, 11:10.
8. Castellucci L., Jamieson S.E., Miller E.N., de Almeida L.F., Oliveira J., Magalhães A., Guimaraes L.H., Lessa M., Lago E., de Jesus A., Carvalho E., Blackwell J.M. FLI1 polymorphism affects susceptibility to cutaneous leishmaniasis in Brazil. Genes Immun. 2011, 12:589-594.
9. Castes M., Trujillo D., Rojas M.E., Fernandez C.T., Araya L., Cabrera M., Blackwell J., Convit J. Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis. Biol. Res. 1993, 26:233-238.
10. Clayton D., Jones H. Transmission disequilibrium tests for extended marker haplotypes. Am. J. Hum. Genet. 1999, 65:1161-1169.
11. Cordell H.J., Barratt B.J., Clayton D.G. Case/pseudocontrol analysis in genetic association studies: a unified framework for detection of genotype and haplotype associations, gene-gene and gene-environment interactions, and parent-of-origin effects. Genet. Epidemiol. 2004, 26:167-185.
12. da Silva L., Neves B.M., Moura L., Cruz M.T., Carvalho E. Neurotensin downregulates the pro-inflammatory properties of skin dendritic cells and increases epidermal growth factor expression. Biochim. Biophys. Acta 2011, 1813:1863-1871.
13. De Franco M., Carneiro Pdos S., Peters L.C., Vorraro F., Borrego A., Ribeiro O.G., Starobinas N., Cabrera W.K., Ibanez O.M. Slc11a1 (Nramp1) alleles interact with acute inflammation loci to modulate wound-healing traits in mice. Mamm. Genome 2007, 18:263-269.
14. El-Safi S., Kheir M.M., Bucheton B., Argiro L., Abel L., Dereure J., Dedet J.P., Dessein A. Genes and environment in susceptibility to visceral leishmaniasis. C. R. Biol. 2006, 329:863-870.
15. Fonseca C., Lindahl G.E., Ponticos M., Sestini P., Renzoni E.A., Holmes A.M., Spagnolo P., Pantelidis P., Leoni P., McHugh N., Stock C.J., Shi-Wen X., Denton C.P., Black C.M., Welsh K.I., du Bois R.M., Abraham D.J. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N. Engl. J. Med. 2007, 357:1210-1220.
16. Galindo M., Santiago B., Rivero M., Rullas J., Alcami J., Pablos J.L. Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression. Arthritis Rheum. 2001, 44:1382-1386.
17. Gressner O.A., Peredniene I., Gressner A.M. Connective tissue growth factor reacts as an IL-6/STAT3-regulated hepatic negative acute phase protein. World J. Gastroenterol. 2011, 17:151-163.
18. Hahm K.B., Cho K., Lee C., Im Y.H., Chang J., Choi S.G., Sorensen P.H., Thiele C.J., Kim S.J. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat. Genet. 1999, 23:222-227.
19. Jirmanus L., Glesby M.J., Guimarães L.H., Lago E., Rosa M.E., Machado P.R., Carvalho E.M. Epidemiological and clinical changes in American tegumentary leishmaniasis in an area of Leishmania (Viannia) braziliensis transmission over a 20year period. Am. J. Trop. Med. Hyg. 2012, 86:426-433.
20. Klass B.R., Grobbelaar A.O., Rolfe K.J. Transforming growth factor beta1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance. Postgrad. Med. J. 2009, 85:9-14.
21. Knapp M. A note on power approximations for the transmission disequilibrium test. Am. J. Hum. Genet. 1999, 64:1177-1185.
22. Kopecki Z., Arkell R.M., Strudwick X.L., Hirose M., Ludwig R.J., Kern J.S., Bruckner-Tuderman L., Zillikens D., Murrell D.F., Cowin A.J. Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita. J. Pathol. 2011, 225:401-413.
23. Lipoldova M., Demant P. Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis. Nat. Rev. Genet. 2006, 7:294-305.
24. Marsden P.D. Mucosal leishmaniasis (" espundia" Escomel, 1911). Trans. R. Soc. Trop. Med. Hyg. 1986, 80:859-876.
25. Mori R., Ikematsu K., Kitaguchi T., Kim S.E., Okamoto M., Chiba T., Miyawaki A., Shimokawa I., Tsuboi T. Release of tumor necrosis factor-a from macrophages is mediated by small GTPase Rab37. Eur. J. Immunol. 2011, 41:3230-3239.
26. Nakerakanti S.S., Kapanadze B., Yamasaki M., Markiewicz M., Trojanowska M. Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program. J. Biol. Chem. 2006, 281:25259-25269.
27. O'Connell J.R., Weeks D.E. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet. 1998, 63:259-266.
28. Pohlers D., Brenmoehl J., Loffler I., Muller C.K., Leipner C., Schultze-Mosgau S., Stallmach A., Kinne R.W., Wolf G. TGF-beta and fibrosis in different organs - molecular pathway imprints. Biochim. Biophys. Acta 2009, 1792:746-756.
29. Pradhan L., Cai X., Wu S., Andersen N.D., Martin M., Malek J., Guthrie P., Veves A., Logerfo F.W. Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing. J. Surg. Res. 2011, 167:336-342.
30. Ramasawmy R., Menezes E., Magalhaes A., Oliveira J., Castellucci L., Almeida R., Rosa M.E., Guimaraes L.H., Lessa M., Noronha E., Wilson M.E., Jamieson S.E., Kalil J., Blackwell J.M., Carvalho E.M., de Jesus A.R. The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. Infect. Genet. Evol. 2010, 10:607-613.
31. Sakthianandeswaren A., Elso C.M., Simpson K., Curtis J.M., Kumar B., Speed T.P., Handman E., Foote S.J. The wound repair response controls outcome to cutaneous leishmaniasis. Proc. Natl. Acad. Sci. USA 2005, 102:15551-15556.
32. Sakthianandeswaren A., Foote S.J., Handman E. The role of host genetics in leishmaniasis. Trends Parasitol. 2009, 25:383-391.
33. Sakthianandeswaren A., Curtis J.M., Elso C., Kumar B., Baldwin T.M., Lopaticki S., Kedzierski L., Smyth G.K., Foote S.J., Handman E. Fine mapping of Leishmania major susceptibility Locus lmr2 and evidence of a role for Fli1 in disease and wound healing. Infect. Immun. 2010, 78:2734-2744.
34. Salhi A., Rodrigues V., Santoro F., Dessein H., Romano A., Castellano L.R., Sertorio M., Rafati S., Chevillard C., Prata A., Alcais A., Argiro L., Dessein A. Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis. J. Immunol. 2008, 180:6139-6148.
35. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
36. Santibanez J.F., Quintanilla M., Bernabeu C. TGF-beta/TGF-beta receptor system and its role in physiological and pathological conditions. Clin. Sci. (London) 2011, 121:233-251.
37. Schriefer A., Guimaraes L.H., Machado P.R., Lessa M., Lessa H.A., Lago E., Ritt G., Goes-Neto A., Schriefer A.L., Riley L.W., Carvalho E.M. Geographic clustering of leishmaniasis in northeastern Brazil. Emerg. Infect. Dis. 2009, 15:871-876.
38. Thaler R., Agsten M., Spitzer S., Paschalis E.P., Karlic H., Klaushofer K., Varga F. Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1 and epigenetic DNA-methylation. J. Biol. Chem. 2011, 286:5578-5588.
39. Thuraisingam T., Sam H., Moisan J., Zhang Y., Ding A., Radzioch D. Delayed cutaneous wound healing in mice lacking solute carrier 11a1 (formerly Nramp1): correlation with decreased expression of secretory leukocyte protease inhibitor. J. Invest. Dermatol. 2006, 126:890-901.
40. Wang Y., Fan P.S., Kahaleh B. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum. 2006, 54:2271-2279.
41. Zaja-Milatovic S., Richmond A. CXC chemokines and their receptors: a case for a significant biological role in cutaneous wound healing. Histol. Histopathol. 2008, 23:1399-1407.